日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumour-reactive heterotypic CD8 T cell clusters from clinical samples

临床样本中的肿瘤反应性异型CD8 T细胞簇

Sofía Ibáñez-Molero #,Johanna Veldman #,Juan Simon Nieto,Joleen J H Traets,Austin George,Kelly Hoefakker,Anita Karomi,Rolf Harkes,Bram van den Broek,Su Min Pack,Liselotte Tas,Nils L Visser,Susan E van Hal-van Veen,Paula Alóndiga-Mérida,Maartje Alkemade,Iris M Seignette,Renaud Tissier,Marja Nieuwland,Martijn van Baalen,Joanna Poźniak,Erik Mul,Simon Tol,Sofia Stenqvist,Lisa M Nilsson,Jonas A Nilsson,John B A G Haanen,Winan J van Houdt,Daniel S Peeper

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis

图卡替尼联合曲妥珠单抗治疗化疗难治性、HER2阳性、RAS野生型转移性结直肠癌(MOUNTAINEER研究):最终分析

Strickler, John H; Cercek, Andrea; Siena, Salvatore; André, Thierry; Ng, Kimmie; Van Cutsem, Eric; Wu, Christina; Paulson, Andrew Scott; Hubbard, Joleen M; Coveler, Andrew L; Fountzilas, Christos; Kardosh, Adel; Kasi, Pashtoon Murtaza; Lenz, Heinz-Josef; Ciombor, Kristen; Elez, Elena; Bajor, David L; Cremolini, Chiara; Sanchez, Federico; Nayeri, Mina; Feng, Wentao; Bieda, Mark; Bekaii-Saab, Tanios S

Heterologous expression and functional characterization of novel microcin B17 congeners from environmental Pseudomonas isolates

从环境假单胞菌分离株中异源表达和新型微生素B17同系物的功能表征

De Smedt, Sandrien; Wéry, Dries; Vande Capelle, Hanne; Gerstmans, Hans; Monsieurs, Pieter; Masschelein, Joleen; Ruelens, Philip; Fauvart, Maarten; Michiels, Jan

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial

新辅助伊匹木单抗和纳武利尤单抗治疗可切除皮肤鳞状细胞癌:一项随机II期试验

Breukers, Sabine E; Traets, Joleen J H; van Dijk, Stan W; Ostos, Mercedes Machuca; Fraterman, Itske; Crommelin, Robert D; van der Hulst, Hedda; Qiao, Xiaohang; Boere, Thomas; van de Poll-Franse, Lonneke V; Retèl, Valesca; van der Noort, Vincent; Vos, Joris L; Toppenberg, Alexandra G L; van der Heijden, Martijn; Missale, Francesco; Balm, Fons; van den Brekel, Michiel; Dirven, Richard; Karakullukcu, M Baris; Karssemakers, Luc; Klop, W Martin C; Lohuis, Peter J F M; Schreuder, Willem H; Smeele, Ludi E; van der Velden, Lilly-Ann; Plasmeijer, Elsemieke; Smit, Laura A; de Boer, Jan Paul; Navran, Arash; Westerink, Bram; de Koekkoek-Doll, Petra K; Castelijns, Jonas; Wondergem, Maurits; Vogel, Wouter V; Kuijpers, Anke; van Houdt, Winan J; Onderwater, Suzanne; Maas-Bannink, Esther; Cornelissen, Sten; Broeks, Annegien; Tijink, Bernard M; Devriese, Lot A; de Bree, Remco; Blank, Christian U; Schumacher, Ton N; Thommen, Daniela S; Haanen, John B A G; Zuur, Charlotte L

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial

Onvansertib 联合化疗和贝伐单抗用于 KRAS 突变转移性结直肠癌的二线治疗:一项单组 II 期试验

Daniel H Ahn, Maya Ridinger, Timothy L Cannon, Lawrence Mendelsohn, Jason S Starr, Joleen M Hubbard, Anup Kasi, Afsaneh Barzi, Errin Samuëlsz, Anju Karki, Ramanand A Subramanian, Divora Yemane, Roy Kim, Chu-Chiao Wu, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz

Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death

基于肝脏硬度和血小板计数的Baveno VII标准在慢性酒精性肝病(cACLD)和临床显著性门静脉高压(CSPH)中的验证和扩展:与肝功能失代偿和死亡风险的相关性

Vutien, Philip; Barnard Giustini, Abbey; Kim, Nicole J; Moon, Andrew M; Hsu, Chun-Nan; Mezzacappa, Catherine; Borgerding, Joleen A; Johnson, Kay M; VoPham, Trang; Berry, Kristin; Beste, Lauren A; Kaplan, David E; Taddei, Tamar H; Ioannou, George N

antiSMASH 8.0: extended gene cluster detection capabilities and analyses of chemistry, enzymology, and regulation

antiSMASH 8.0:扩展了基因簇检测功能,并增加了化学、酶学和调控分析。

Blin, Kai; Shaw, Simon; Vader, Lisa; Szenei, Judit; Reitz, Zachary L; Augustijn, Hannah E; Cediel-Becerra, José D D; de Crécy-Lagard, Valérie; Koetsier, Robert A; Williams, Sam E; Cruz-Morales, Pablo; Wongwas, Sopida; Segurado Luchsinger, Alejandro E; Biermann, Friederike; Korenskaia, Aleksandra; Zdouc, Mitja M; Meijer, David; Terlouw, Barbara R; van der Hooft, Justin J J; Ziemert, Nadine; Helfrich, Eric J N; Masschelein, Joleen; Corre, Christophe; Chevrette, Marc G; van Wezel, Gilles P; Medema, Marnix H; Weber, Tilmann

Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer

用于治疗铂耐药性卵巢癌的髓系靶向抗体 PY159 和 PY314

Yeku, Oladapo O; Barve, Minal; Tan, Winston W; Wang, Judy; Patnaik, Amita; LoRusso, Patricia; Richardson, Debra L; Naqash, Abdul Rafeh; Lynam, Sarah K; Fu, Siqing; Gordon, Michael; Hubbard, Joleen; Kummar, Shivaani; Kyriakopoulos, Christos; Dowlati, Afshin; Chamberlain, Marc; Winer, Ira

Multiplexed bacteriocin synthesis to combat and prevent antimicrobial resistance

多重细菌素合成用于对抗和预防抗菌素耐药性

Quintero-Yanes, Alex; Petit, Kenny; Rodriguez-Villalobos, Hector; Vande Capelle, Hanne; De Veirman, Olivier; Gerstmans, Hans; Masschelein, Joleen; Borrero, Juan; Hols, Pascal; Gabant, Philippe

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

一项针对携带FGFR改变的转移性或不可切除性结直肠癌患者的pemigatinib II期多中心单臂研究

Wheless, Margaret C; Zemla, Tyler J; Hubbard, Joleen M; Strickler, John H; Gbolahan, Olumide B; Wilson, Luke; Waechter, Blake; Ou, Fang-Shu; Nixon, Andrew B; Bekaii-Saab, Tanios S; Ciombor, Kristen K